Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Oct 17, 2023

BUY
$191.51 - $216.16 $25.9 Million - $29.3 Million
135,500 Added 852.2%
151,400 $32.1 Million
Q2 2023

Jul 12, 2023

SELL
$187.64 - $206.25 $900,671 - $990,000
-4,800 Reduced 23.19%
15,900 $3.06 Million
Q1 2023

Apr 28, 2023

BUY
$127.59 - $203.08 $2.64 Million - $4.2 Million
20,700 New
20,700 $4.19 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.